Skip to main contentU.S. National Library of MedicineU.S. National Library of Medicine

Profiles in Science
Pinterest badge Follow Profiles in Science on Pinterest!

The Maxine Singer Papers

Letter from Charles Warren and Barry Keene to Maxine Singer pdf (104,030 Bytes) transcript of pdf
Letter from Charles Warren and Barry Keene to Maxine Singer
During the second half of the 1970s, Singer testified as an expert witness on the promise, risks, and safety management of recombinant DNA research before municipal officials, state legislators, and Congress.
Number of Image Pages:
2 (104,030 Bytes)
1976-12-29 (December 29, 1976)
Warren, Charles
Keene, Barry
California. State Assembly
Singer, Maxine
Original Repository: Library of Congress. Maxine Singer Papers
Reproduced with permission of Barry Keene.
Medical Subject Headings (MeSH):
DNA, Recombinant
Risk Assessment
Exhibit Category:
Risk, Regulation, and Scientific Citizenship: The Controversy over Recombinant DNA Research
Metadata Record Letter from Maxine Singer to Charles Warren (January 7, 1977) pdf (45,837 Bytes) transcript of pdf
Box Number: 33
Folder Number: 4
Unique Identifier:
Document Type:
Letters (correspondence)
Physical Condition:
Series: Recombinant DNA File, 1972-1980, n.d.
SubSeries: Binders
Folder: Nos. 3-6, 1976 November-1977 February
December 29, 1976
Dear Dr. Singer:
This letter is to request your participation in a legislative hearing on the public health and safety implications of public and private recombinant DNA research in California. The hearings will be held under the joint aegis of the California Assembly Committee on Resources, Land Use, and Energy and the Assembly Committee on Health. They will commence Friday, January 21, 1977 in Sacramento, California, and will continue for three consecutive Fridays.
We have tentatively scheduled consinderation of the NIH guidelines for the third hearing date, Friday, February 11, 1977 at 9:30 a.m. in Room 4202 of the state Capitol. In view of your thorough familiarity with the issue and your role as public spokesman for NIH, we would solicit your testimony as lead-off witness for that phase of the hearings.
Our purpose is to understand the nature and benefits of recombinant DNA and related forms of research, as well as the potential hazards. We are aware of the numerous disparate viewpoints held as to the actual level of public risk, if any, associated with the research. We intend to fully and responsibly explore this range of opinions so that the information we develop will be as accurate and complete as possible.
We would very much appreciate your participation and guidance.
Charles Warren, Chairman
Assembly Committee on Resources, Land Use, and Energy
Barry Keene, Chairman
Assembly Committee on Health
Metadata Last Modified Date:
Linked Data:
RDF/XML     JSON     JSON-LD     N3/Turtle     N-Triples